Cipla (EU) Limited’s acquisition of additional 15.10% stake in Cipla Maroc SA’s operations in Morocco for MAD 81.1 million

Lead party: Cipla (EU) Limited (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Cipla Maroc SA (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Morocco Transaction type: Investment · Asset class: Corporate Transactions · Strategy: Secondary Sale · Instrument: Equity · Deal amount: US$8m · Equity…


Lead party: Cipla (EU) Limited (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Cipla Maroc SA (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Morocco

Transaction type: Investment · Asset class: Corporate Transactions · Strategy: Secondary Sale · Instrument: Equity · Deal amount: US$8m · Equity stake: 0.151% · Implied EV: US$53.2m

Lead investor/buyer: Cipla (EU) Limited · Investors/buyers: Cipla (EU) Limited · Sellers: The Pharmaceutical Institute

Legal advisers: not identified in the source record.

Source: announced 13 September 2023. Original announcement: cipla.com.